Meera Ragavan, MD, MPH
Adjunct Instructor
Medicine
School of Medicine

My research interests are centered around issues of affordability and equity in cancer care delivery and designing and implementing interventions to mitigate these growing challenges, particularly for patients with lung cancer. I also study the impact of telehealth on cancer outcomes and payor-related barriers to timely, high-quality care. I have a BA/BS in biology & economics from the University of Pennsylvania, an MD from Stanford School of Medicine, and an MPH from Harvard T.H Chan School of Public Health.

• Clinical Validity and Utility of Circulating Tumor DNA (ctDNA) Testing in Advanced Non-small Cell Lung Cancer (aNSCLC): A Systematic Literature Review and Meta-analysis.
  Molecular diagnosis & therapy 2024 Chen C, Douglas MP, Ragavan MV, Phillips KA, Jansen JP
• Beyond the PSA: The hidden costs of screening in prostate cancer.
  Cancer 2024 Sanyal C, Ragavan MV
• Receipt of financial assistance for oral targeted therapy among older adults with advanced non-small cell lung cancer: A prospective cohort study.
  Journal of geriatric oncology 2024 Kumar A, Ragavan M, Velazquez AI, Zeng S, Wong ML
• Lay healthcare worker financial toxicity intervention: a pilot financial toxicity screening and referral program.
  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2024 Parikh DA, Rodriguez GM, Ragavan M, Kerr E, Asuncion MK, Hansen J, Srinivas S, Fan AC, Shah S, Patel MI
• Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study.
  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 Nassar AH, Kim SY, Aredo JV, Feng J, Shepherd F, Xu C, Kaldas D, Gray JE, Dilling TJ, Neal JW, Wakelee HA, Liu Y, Lin SH, Abuali T, Amini A, Nie Y, Patil T, Lobachov A, Bar J, Fitzgerald B, Fujiwara Y…
• Pharmacy Assistance Programs for Oral Anticancer Drugs: A Narrative Review.
  JCO oncology practice 2024 Ragavan MV, Swartz S, Clark M, Chino F
• Access to Financial Assistance Programs and Their Impact on Overall Spending on Oral Anticancer Medications at an Integrated Specialty Pharmacy.
  JCO oncology practice 2024 Ragavan MV, Swartz S, Clark M, Lo M, Gupta A, Chino F, Lin TK
• Clinical validity and utility of circulating tumor DNA (ctDNA) testing in advanced non-small cell lung cancer (aNSCLC): a systematic literature review and meta-analysis.
  medRxiv : the preprint server for health sciences 2023 Chen C, Douglas MP, Ragavan MV, Phillips KA, Jansen JP
• The Health Inequality Impact of Liquid Biopsy to Inform First-Line Treatment of Advanced Non-Small Cell Lung Cancer: A Distributional Cost-Effectiveness Analysis.
  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2023 Jansen JP, Ragavan MV, Chen C, Douglas MP, Phillips KA
• Private Payer and Medicare Coverage Policies for Use of Circulating Tumor DNA Tests in Cancer Diagnostics and Treatment.
  Journal of the National Comprehensive Cancer Network : JNCCN 2023 Douglas MP, Ragavan MV, Chen C, Kumar A, Gray SW, Blakely CM, Phillips KA
• The costs and inequities of precision medicine for patients with prostate cancer: A call to action.
  Urologic oncology 2023 Ragavan MV, Borno HT
• Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic.
  JAMA oncology 2022 Ragavan MV, Legaspi N, LaLanne A, Hong JC, Small EJ, Borno HT
• Impact of a Comprehensive Financial Resource on Financial Toxicity in a National, Multiethnic Sample of Adult, Adolescent/Young Adult, and Pediatric Patients With Cancer.
  JCO oncology practice 2022 Ragavan MV, Mora RV, Winder K, Incudine A, Cunningham R, Stivers T, Borno HT
• Estimating maternity ward birth attendant time use in India: a microcosting study.
  BMJ open 2022 Lofgren KT, Bobanski L, Tuller DE, Singh VP, Marx Delaney M, Jurczak A, Ragavan M, Kalita T, Karlage A, Resch SC, Semrau KEA
• The evolving landscape of sex-based differences in lung cancer: a distinct disease in women.
  European respiratory review : an official journal of the European Respiratory Society 2022 Ragavan M, Patel MI
• Financial Toxicity of Cancer Care: An Analysis of Financial Burden in Three Distinct Health Care Systems.
  JCO oncology practice 2021 Parikh DA, Ragavan M, Dutta R, Garnet Edwards J, Dickerson J, Maitra D, Aggarwal S, Lee FC, Patel MI
• Defining the clinician's role in mitigating financial toxicity: an exploratory study.
  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2021 Ragavan M, Parikh D, Patel M
• Healthcare delivery interventions to reduce cancer disparities worldwide.
  World journal of clinical oncology 2020 Dickerson JC, Ragavan MV, Parikh DA, Patel MI
• Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy.
  Current treatment options in oncology 2020 Ragavan M, Das M
• Understanding sex disparities in lung cancer incidence: are women more at risk?
  Lung cancer management 2020 Ragavan MV, Patel MI
• Association Between HEDIS Performance and Primary Care Physician Age, Group Affiliation, Training, and Participation in ACA Exchanges.
  Journal of general internal medicine 2020 Glassman JR, Hopkins DSP, Bundorf MK, Kaplan RM, Ragavan MV, Glaseroff A, Milstein A
• Exploring Care Attributes of Nephrologists Ranking Favorably on Measures of Value.
  Journal of the American Society of Nephrology : JASN 2019 Brady BM, Ragavan MV, Simon M, Chertow GM, Milstein A
• Barriers to timely discharge from the general medicine service at an academic teaching hospital.
  Postgraduate medical journal 2017 Ragavan MV, Svec D, Shieh L
• Scheduled surgery admissions and occupancy at a children's hospital: variation we can control to improve efficiency and value in health care delivery.
  Annals of surgery 2013 Ragavan MV, Blinman TA, Fieldston ES
• Traditional measures of hospital utilization may not accurately reflect dynamic patient demand: findings from a children's hospital.
  Hospital pediatrics 2012 Fieldston E, Ragavan M, Jayaraman B, Metlay J, Pati S
• Scheduled admissions and high occupancy at a children's hospital.
  Journal of hospital medicine 2010 Fieldston ES, Ragavan M, Jayaraman B, Allebach K, Pati S, Metlay JP